Recombinant Protein Production News and Research

RSS
Recombinant protein may treat male factor fertility

Recombinant protein may treat male factor fertility

Medicago, IDRI receive FDA approval to commence Phase 1 H5N1 vaccine trial

Medicago, IDRI receive FDA approval to commence Phase 1 H5N1 vaccine trial

CSIRO to produce antibodies for development of new vaccines against rotavirus

CSIRO to produce antibodies for development of new vaccines against rotavirus

FDA grants Fast Track designation to Edimer’s EDI200 for treatment of XLHED

FDA grants Fast Track designation to Edimer’s EDI200 for treatment of XLHED

Clinical and Translational Science Institute-Children's National awards pilot grant to GW researchers

Clinical and Translational Science Institute-Children's National awards pilot grant to GW researchers

Crucell, ARTES enter research collaboration to develop two vaccines

Crucell, ARTES enter research collaboration to develop two vaccines

RI Hospital to study treatment that may prevent post-traumatic OA

RI Hospital to study treatment that may prevent post-traumatic OA

Actavis, Scil Proteins sign Reteplase supply agreement

Actavis, Scil Proteins sign Reteplase supply agreement

Adeona to develop and commercialize DNA-based therapeutic for PAH using Intrexon technology

Adeona to develop and commercialize DNA-based therapeutic for PAH using Intrexon technology

EPO-secreting engineered vessels could reverse anemia

EPO-secreting engineered vessels could reverse anemia

Scil Proteins completes manufacturing agreement with Lundbeck

Scil Proteins completes manufacturing agreement with Lundbeck

HHS' BARDA contract advances development of novel anthrax vaccine, antitoxin

HHS' BARDA contract advances development of novel anthrax vaccine, antitoxin

Bruker releases new amaZon speed ion trap mass spectrometers

Bruker releases new amaZon speed ion trap mass spectrometers

Nature Biotechnology publishes BGI, GT Life Sciences' study on CHO K1 genome

Nature Biotechnology publishes BGI, GT Life Sciences' study on CHO K1 genome

Repligen first quarter total revenue increases 9% to $7,654,000

Repligen first quarter total revenue increases 9% to $7,654,000

Scil Technology receives public research grant for novel rheumatoid arthritis treatments

Scil Technology receives public research grant for novel rheumatoid arthritis treatments

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced melanoma

Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced melanoma

BPD expands existing bioprocess and scale-up laboratory in Poway, CA

BPD expands existing bioprocess and scale-up laboratory in Poway, CA

ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer

ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer